SIR-Spheres Microspheres
Device Interventional Oncology
General payments
$14,693,786
Research payments
$7,238,414
Through program year 2025, $14,693,786 in general payments and $7,238,414 in research payments were reported against SIR-Spheres Microspheres (Interventional Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
14 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $2,088,531 | 3,830 |
| 2025 | Research | $895,282 | 83 |
| 2024 | General | $2,287,852 | 4,496 |
| 2024 | Research | $1,722,853 | 166 |
| 2023 | General | $1,790,428 | 3,752 |
| 2023 | Research | $1,961,527 | 114 |
| 2022 | General | $1,707,290 | 3,783 |
| 2022 | Research | $1,309,095 | 119 |
| 2021 | General | $1,843,703 | 2,784 |
| 2021 | Research | $1,171,997 | 307 |
| 2020 | General | $1,978,534 | 3,736 |
| 2020 | Research | $172,660 | 5 |
| 2019 | General | $2,997,449 | 6,654 |
| 2019 | Research | $5,000 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 56 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
29,035 general · 795 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.